Statistically developed docetaxel-laden mixed micelles for improved therapy of breast cancer

• Autores principales: Smita S. Patil (Autor), Rutuja D. Chougale (Autor), Arehalli S. Manjappa (Autor), John I. Disouza (Autor), Ashok A. Hajare (Autor), Kiran S. Patil (Autor)
• Formato: Libro
• Publicado: Elsevier, 2022-11-01T00:00:00Z.
• Materias: article
• Acceso en línea: Connect to this object online.

Docetaxel (DTX) has poor solubility, serious side effects, and multi-drug resistance (MDR) limiting its use in cancer treatment. Hence, the present study aimed to formulate and develop docetaxel mixed micelles (DTX MMs) for breast cancer treatment. DTX MMs were prepared from a mixture of docetaxel,...